SELE and breast carcinoma: Particularly, the E-selectin interacts with its ligands expressed on breast cancer cells, including platelet selectin glycoprotein ligand-1 (PSGL-1), cluster of differentiation 24 (CD24), sialyl-Lewis X (sLex), and mucin-1 (MUC1) to allow rolling [28,29].